Skip to main content
NIH funding notice RFA-AI-22-002

Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U01 Clinical Trial Not Allowed)

Closed on May 13, 2022.

Posted
January 18, 2022
Close date
May 13, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,075,240 in first-year total cost, median $1,075,240.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 AM-I (J1)]1

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
Competing awards under RFA-AI-22-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Targeting innate immunity for induction of robust renal allograft tolerance1U01AI174968-01ARNAOUT, M. AMINKAWAI, TATSUOMASSACHUSETTS GENERAL HOSPITAL, MA$1,075,240ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.